|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
1R01CA186338-01A1
|
$362,685
|
$362,685
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
$1,400
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
$12,419
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$1,872
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$78,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
$77,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Ou
|
ZIA CP010126 - 00580
|
$39,863
|
$1,993
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Validation of pancreatic cancer biomarkers in large prospective cohorts
|
1R01CA196286-01A1
|
$516,804
|
$516,804
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
5R21CA182692-02
|
$168,563
|
$168,563
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-02
|
$700,000
|
$8,750
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
3U10CA180858-02S1
|
$100,000
|
$1,250
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-02
|
$1,192,600
|
$14,908
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
5R01CA176828-03
|
$416,661
|
$416,661
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Use of DND1 to counteract miRNA function in cancers
|
5R21CA175833-02
|
$174,000
|
$174,000
|
MATIN, ANGABIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$625
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$62,312
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-29S1
|
$89,185
|
$25,864
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
$430,650
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$15,876
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$487,809
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$11,867
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$3,749
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$2,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$6,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$46,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-02
|
$377,902
|
$94,476
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$925,596
|
$92,560
|
Gu, Shuo
|
CCR (NCI)
|
|
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pan
|
1U01CA198846-01
|
$513,147
|
$513,147
|
NEL, ANDRE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UCDCCC NCTN U10 Program
|
3U10CA180846-02S1
|
$99,708
|
$4,985
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-02
|
$630,226
|
$31,511
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Two phospho-compounds for pancreatic cancer prevention
|
1R21CA185209-01A1
|
$206,190
|
$206,190
|
MACKENZIE, GERARDO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanc
|
1R01CA198096-01
|
$452,195
|
$452,195
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$376,957
|
$37,696
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-18
|
$1,585,768
|
$428,157
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
6F31CA183493-02
|
$47,676
|
$23,838
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer
|
5R01CA170946-04
|
$481,186
|
$481,186
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA
|
|
Treating pancreatic cancer with Listeria-32P
|
1R21CA199010-01
|
$16,676
|
$16,676
|
GRAVEKAMP, CLAUDIA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Treating pancreatic cancer with Listeria-32P
|
6R21CA199010-02
|
$201,259
|
$201,259
|
GRAVEKAMP, CLAUDIA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Translational Research in Cancer
|
5P30CA056036-16
|
$2,807,751
|
$196,543
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression
|
5F30CA177123-03
|
$29,785
|
$29,785
|
FERREIRA, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training Program in Molecular Oncology and Immunology
|
5T32CA009161-40
|
$696,122
|
$139,224
|
LEVY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Toll-like Receptor Regulation of Pancreatic Tumorigenesis
|
5R01CA168611-03
|
$351,713
|
$351,713
|
MILLER, GEORGE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
|
ZID BC 011540
|
$1,260,216
|
$252,043
|
Hassan, Raffit
|
CCR (NCI)
|
|
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225
|
5R21CA173120-02
|
$201,799
|
$201,799
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec Assa
|
1R21CA189775-01A1
|
$202,438
|
$202,438
|
LUBMAN, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Therapeutic evaluation in GEM pancreatic model
|
ZIA BC 011526
|
$172,904
|
$86,452
|
Van Dyke, Terry
|
CCR (NCI)
|
|
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
|
5R01CA187090-02
|
$322,663
|
$322,663
|
YI, CHUNLING
|
GEORGETOWN UNIVERSITY
|
Total relevant funding to Pancreas for this search: $125,247,562
|